• Key takeaways from pillar two developments  

    Latest developments regarding Global Anti-Base Erosion Model Rules (Pillar Two)

    Read more
  • Chambers & Partners Europe rank

    We’re delighted to share that Andersen´s Corporate and M&A team has been recognized in the Chambers and Partners Europe 2023 Directory.

    Read more
  • LEGAL 500 2023 – Our lawyers in prestigious positions again

    The office has repeated the great results of the previous year.

    Read more
  • M&A Full Year Review

    Despite the fact that the total number of deals in 2022 fell short of the record-breaking number of deals achieved in 2021, they still managed to exceed pre-pandemic levels.

    Read more
  • Extended Producer Responsibility – Significant changes in the Hungarian green tax legislation

    In the following, we summarize the most important changes starting 1 July 2023.

    Read more
  • Szabó Kelemen & Partners Andersen Attorneys ranked in Chambers Europe 2023

    The firm is ranked in the Employment category.

    Read more
  • Southeast Asian tax specialist joined Andersen Hungary

    Interview with Ngwe Lin Myat Chit, the new senior tax advisor of Andersen.

    Read more
  • DEBRA directive: tackling debt-equity bias

    According to the EU, the tax-driven debt-equity bias results in favouring the use of debt over equity for investment financing, creating an unstable and vulnerable economic environment.

    Read more
  • Andersen well ahead of growth plans

    The sales revenue of Andersen Adótanácsadó Zrt. reached HUF 2.1 billion in 2022, which is almost 40 percent up on the previous year.

    Read more
  • Changes in Hungarian competition law

    The Act LVII of 1996 on the prohibition of unfair market practices and the restriction of competition was substantially modified by the Act LV of 2022, in principle with effect from 1 January 2023.

    Read more
  • Christmas surtax changes affecting pharmaceutical manufacturers and the insurance sector

    The range of taxpayers obliged to pay special surtaxes was extended to include pharmaceutical manufacturers.

    Read more
  • Stricter transfer pricing rules were published

    The new rules are already in part applicable to the intra-group transactions of 2022.

    Read more